Guggenheim Downgrades The Honest Co. (HNST) to Neutral

Go back to Guggenheim Downgrades The Honest Co. (HNST) to Neutral

The Honest Co. (HNST) PT Lowered to $12 at Telsey

March 25, 2022 5:25 AM EDT

Telsey analyst Dana Telsey lowered the price target on The Honest Co. (NASDAQ: HNST) to $12.00 (from $18.00) while maintaining a Outperform rating.... More

UPDATE: Jefferies Downgrades The Honest Co. (HNST) to Hold

March 25, 2022 4:16 AM EDT

(Updated - March 25, 2022 8:00 AM EDT)

Jefferies analyst Stephanie Wissink downgraded The Honest Co. (NASDAQ: HNST) from Buy to Hold with a price target of $5.00 (from $11.00).

The analyst commented, "We are stepping to the sidelines, downgrading to Hold, to reevaluate the model... More

The Honest Co. (HNST) PT Lowered to $8.25 at Morgan Stanley

March 25, 2022 3:08 AM EDT

Morgan Stanley analyst Dara Mohsenian lowered the price target on The Honest Co. (NASDAQ: HNST) to $8.25 (from $9.00) while maintaining a Equalweight rating.... More

The Honest Company's (HNST) Shares Plunge 20% on Q4 Miss

March 24, 2022 6:02 PM EDT

The Honest Company Inc. (NASDAQ: HNST) shares dropped around 20% after-hours following the companys Q4 results, with EPS of ($0.10) coming in worse than the consensus estimate of ($0.06).

Revenue grew 3% year-over-year to $80.4 million, compared to the consensus of $84.59 million, primarily due to... More

After-Hours Stock Movers 03/24: (TLRY) (SNDL) (CRON) Higher; (MEIP) (HNST) (SMRT) Lower

March 24, 2022 5:25 PM EDT

After-Hours Stok Movers:

MEI Pharma (NASDAQ: MEIP) 46% LOWER; FDA informed the companies of its position that a randomized trial is now needed to adequately assess drug efficacy and safety of PI3K inhibitor drug candidates

The Honest Company Inc. (NASDAQ: HNST) 20% LOWER; reported Q4 EPS of ($0.10), $0.04 worse than the... More

The Honest Company Inc. (HNST) Misses Q4 EPS by 4c, Offers Outlook

March 24, 2022 4:07 PM EDT

The Honest Company Inc. (NASDAQ: HNST) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $80.4 million versus the consensus estimate of $84.59 million.

Full Year 2022 Outlook:

RevenueFull Year 2022 revenue is expected... More